These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Captopril--an inhibitor of the angiotensin I converting enzyme--in the treatment of arterial hypertension in chronic kidney failure patients]. Manasia M, Paţiu IM, Vlăduţiu D, Madi A, Barabas E, Gherman M. Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1985; 37(3):217-22. PubMed ID: 2865784 [No Abstract] [Full Text] [Related]
43. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators. Konstam MA, Kronenberg MW, Rousseau MF, Udelson JE, Melin J, Stewart D, Dolan N, Edens TR, Ahn S, Kinan D. Circulation; 1993 Nov; 88(5 Pt 1):2277-83. PubMed ID: 8222122 [Abstract] [Full Text] [Related]
46. [Acute pharmacological block of the renin-angiotensin system and the recovery of intrarenal hemodynamics in patients with chronic glomerulonephritis]. Kutyrina IM, Tareeva IE, Zverev KV, Rogov VA. Ter Arkh; 1993 Nov; 65(6):13-7. PubMed ID: 8378838 [Abstract] [Full Text] [Related]
49. Concomitant administration of isradipine and spirapril prevents reduction of renal function induced by acute administration of spirapril in patients with reduced renal function. Wittenberg C, Erman A, Shohat J, Boner G. Blood Press Suppl; 1994 Nov; 1():48-9. PubMed ID: 8205299 [Abstract] [Full Text] [Related]
50. Angiotensin converting enzyme inhibitors and cough. Town GI, Hallwright GP, Maling TJ, O'Donnell TV. N Z Med J; 1987 Mar 25; 100(820):161-3. PubMed ID: 2837699 [Abstract] [Full Text] [Related]
54. ACE-inhibitors in the treatment of elderly hypertensives. M'Buyamba-Kabangu JR, Fagard R, Lijnen P, Staessen J, Van Hoof R, Amery A. Geriatrics; 1987 Jun 25; 42(6):45-9. PubMed ID: 3034739 [Abstract] [Full Text] [Related]
55. Effect of enalapril on renal profile and right ventricular dimensions in chronic cor pulmonale. Mahajan SK, Sharma VK, Thakral S. J Assoc Physicians India; 1996 May 25; 44(5):323-4. PubMed ID: 9282581 [Abstract] [Full Text] [Related]
56. Reduction of QT and QTc dispersion during long-term treatment of systemic hypertension with enalapril. González-Juanatey JR, García-Acuña JM, Pose A, Varela A, Calvo C, Cabezas-Cerrato J, de la Peña MG. Am J Cardiol; 1998 Jan 15; 81(2):170-4. PubMed ID: 9591900 [Abstract] [Full Text] [Related]
57. Beneficial effects of nicorandil versus enalapril in chronic rheumatic severe mitral regurgitation: six months follow up echocardiographic study. Gupta DK, Kapoor A, Garg N, Tewari S, Sinha N. J Heart Valve Dis; 2001 Mar 15; 10(2):158-65. PubMed ID: 11297201 [Abstract] [Full Text] [Related]
58. Enalapril influence on blood pressure and echocardiographic parameters in children with acute postinfectious glomerulonephritis. Jankauskiene A, Cerniauskiene V, Jakutovic M, Malikenas A. Medicina (Kaunas); 2005 Mar 15; 41(12):1019-25. PubMed ID: 16401958 [Abstract] [Full Text] [Related]
59. Control of hypertension and reversal of renal failure in undifferentiated connective tissue disease by enalapril. Strongwater SL, Galvanek EG, Stoff JS. Arch Intern Med; 1989 Mar 15; 149(3):582-5. PubMed ID: 2537611 [Abstract] [Full Text] [Related]
60. [Do we need more ACE inhibitors?]. Haugen O. Tidsskr Nor Laegeforen; 1990 Apr 30; 110(11):1411. PubMed ID: 2187274 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]